BMCM
ELV icon

Bryn Mawr Capital Management’s Elevance Health ELV Stock Holding History

Bryn Mawr Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
+658
New +$244K 0.01% 404
2026
Q1 		– Sell
-632
Closed -$222K – 449
2025
Q4 		$222K Sell
632
-78
-11% -$26.4K 0.01% 419
2025
Q3 		$229K Buy
710
+4
+0.6% +$1.24K 0.01% 404
2025
Q2 		$275K Sell
706
-633
-47% -$255K 0.02% 355
2025
Q1 		$582K Sell
1,339
-904
-40% -$363K 0.03% 241
2024
Q4 		$827K Buy
2,243
+1
+0% +$418 0.04% 234
2024
Q3 		$1.17M Sell
2,242
-42
-2% -$22.4K 0.06% 200
2024
Q2 		$1.24M Buy
2,284
+5
+0.2% +$2.64K 0.07% 195
2024
Q1 		$1.18M Sell
2,279
-160
-7% -$79.6K 0.07% 207
2023
Q4 		$1.15M Sell
2,439
-85
-3% -$39.3K 0.07% 199
2023
Q3 		$1.1M Buy
2,524
+8
+0.3% +$3.63K 0.07% 200
2023
Q2 		$1.12M Buy
2,516
+127
+5% +$58.6K 0.11% 158
2023
Q1 		$1.1M Sell
2,389
-75
-3% -$35.7K 0.11% 153
2022
Q4 		$1.26M Buy
+2,464
New +$1.25M 0.14% 134

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bryn Mawr Capital Management's ELV Position: Q2 2026 in Review

Bryn Mawr Capital Management opened a new position in Elevance Health (ELV) in Q2 2026: 658 shares worth $254K. The stake represents 0.01% of the portfolio and ranks #404 among its holdings. This is a return to the name: Bryn Mawr Capital Management previously reported a position in ELV as recently as Q4 2025.

Bryn Mawr Capital Management first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.26M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bryn Mawr Capital Management held 658 shares of Elevance Health worth $254K as of Q2 2026.
  • Elevance Health was a new Bryn Mawr Capital Management position in Q2 2026.
  • Elevance Health made up 0.01% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #404 holding.
  • Bryn Mawr Capital Management first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Bryn Mawr Capital Management's Elevance Health position peaked at $1.26M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.